I'm LongbridgeAI, I can summarize articles.In Monday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Innovative Eyewear (LUCY) up 63.6%, Picard Medical (PMI) up 39.25%, and Aprea Therapeutics (APRE) up 23.52%. Conversely, major losers featured Regenxbio (RGNX) down 25.3% and Bristol-Myers Squibb Celegne Contingent Value Rights (CELGR) down 22.92%. Market caps ranged from millions to billions, with some movements linked to recent Q2 earnings reports.
Gainers
- Innovative Eyewear (NASDAQ:LUCY) stock rose 63.6% to $1.12 during Monday's regular session. The market value of their outstanding shares is at $5.8 million.
- Picard Medical (AMEX:PMI) shares increased by 39.25% to $4.47. The company's market cap stands at $6.5 million. As per the news, the Q2 earnings report came out 3 days ago.
- Aprea Therapeutics (NASDAQ:APRE) stock increased by 23.52% to $0.79. The company's market cap stands at $8.0 million.
- Alvotech (NASDAQ:ALVO) stock increased by 18.22% to $5.24. The company's market cap stands at $1.4 billion. As per the press release, Q2 earnings came out 3 days ago.
- Biomea Fusion (NASDAQ:BMEA) stock moved upwards by 16.78% to $1.6. The market value of their outstanding shares is at $99.3 million.
- Nutriband (NASDAQ:NTRB) shares increased by 15.08% to $5.37. The market value of their outstanding shares is at $56.7 million.
Losers
- Regenxbio (NASDAQ:RGNX) stock fell 25.3% to $8.01 during Monday's regular session. The company's market cap stands at $707.6 million.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock fell 22.92% to $0.09.
- Addex Therapeutics (NASDAQ:ADXN) stock fell 22.07% to $3.85. The company's market cap stands at $6.0 million.
- Kairos Pharma (AMEX:KAPA) shares decreased by 20.69% to $0.23. The market value of their outstanding shares is at $6.8 million.
- Adial Pharmaceuticals (NASDAQ:ADIL) shares decreased by 18.13% to $5.09. The market value of their outstanding shares is at $16.3 million.
- Profusa (NASDAQ:PFSA) shares declined by 17.95% to $4.48. The market value of their outstanding shares is at $2.8 million. As per the press release, Q2 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock1,059characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.